Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22789,97,1.00 [0.77-1.29],0.9970296196813518
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23413,178,0.91 [0.74-1.12],0.3930358884008047
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23185,1137,1.01 [0.93-1.08],0.868348056345134
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23444,408,1.15 [1.04-1.28],0.0082159990159158
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22711,2985,0.99 [0.95-1.04],0.6747040851749336
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22910,2418,0.99 [0.94-1.04],0.7008416663660009
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23197,1140,0.95 [0.88-1.03],0.2013186485043992
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23340,79,1.06 [0.81-1.38],0.6726482015509907
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21891,685,1.01 [0.92-1.11],0.7560061764963201
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21143,784,1.03 [0.95-1.12],0.4837784626207192
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21201,218,1.14 [0.99-1.32],0.0749435024497439
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16435,1389,0.97 [0.90-1.04],0.3525479463643013
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21008,313,0.98 [0.85-1.14],0.8301650955622953
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23381,1324,0.97 [0.90-1.04],0.335710828895233
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23495,459,1.13 [1.02-1.25],0.0181333579025738
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22850,802,1.01 [0.93-1.10],0.8191094235933695
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23444,752,1.01 [0.93-1.11],0.7490720515405509
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22235,178,0.91 [0.74-1.12],0.3724233312464836
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23548,35,1.23 [0.88-1.71],0.2263577232410313
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23356,664,1.02 [0.93-1.12],0.6652222041267963
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23336,75,0.76 [0.52-1.11],0.1547784436966425
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23463,164,0.95 [0.78-1.17],0.6348699915738448
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23449,150,0.91 [0.73-1.14],0.4097253289310757
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22338,290,1.04 [0.90-1.20],0.5782087209481235
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22270,222,0.96 [0.80-1.14],0.6290578205816222
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22153,96,1.17 [0.95-1.45],0.1420325794046392
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23525,33,0.97 [0.61-1.53],0.8944899286406264
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23484,141,0.89 [0.70-1.13],0.3395572440139627
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23384,41,0.96 [0.64-1.44],0.8416251764693476
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23414,71,0.79 [0.55-1.15],0.2253204932805081
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23317,201,0.93 [0.77-1.12],0.435106916993189
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23460,57,1.16 [0.88-1.52],0.2891581685547417
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23455,58,0.84 [0.56-1.24],0.3707928152784572
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23300,1042,1.03 [0.95-1.11],0.491058168712039
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of meninges,23524,72,0.85 [0.61-1.21],0.3729401208451194
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23489,57,0.96 [0.68-1.35],0.7989891267250149
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23518,107,1.17 [0.95-1.43],0.1414434084371551
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of ovary,23480,148,1.08 [0.89-1.30],0.4335809939368983
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23528,235,0.97 [0.82-1.15],0.7646229751939654
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23534,214,0.89 [0.74-1.08],0.252580005816257
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23468,54,0.72 [0.45-1.15],0.1710427119494545
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23533,131,1.06 [0.87-1.30],0.5739574213082975
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23494,239,1.09 [0.94-1.26],0.2402349548541585
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23452,437,1.13 [1.02-1.25],0.0228925370960153
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23534,252,1.05 [0.91-1.22],0.5068819623517742
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Carcinoma in situ of breast,19054,119,0.93 [0.73-1.19],0.5517369283166704
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19126,138,0.96 [0.77-1.19],0.6951623675033523
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19121,30,0.65 [0.33-1.28],0.2116338072929048
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19147,56,0.93 [0.65-1.33],0.6777902057587595
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23484,124,1.10 [0.90-1.34],0.358893541761026
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Haemangioma, any site",23485,122,1.08 [0.88-1.33],0.4408406788417263
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Leiomyoma of uterus,22685,498,1.08 [0.98-1.19],0.134391262862462
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Lung cancer and mesothelioma,16927,277,1.09 [0.95-1.26],0.2243233466759968
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Lymphoid leukaemia,19125,34,0.93 [0.59-1.48],0.7708759118856263
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19243,152,0.88 [0.70-1.11],0.2756362774329233
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19186,95,0.95 [0.72-1.24],0.6957290419326984
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19251,160,0.97 [0.79-1.19],0.7560178117642595
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19152,61,0.94 [0.67-1.32],0.7215244455744945
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19152,61,0.92 [0.64-1.30],0.6224432621386563
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19137,46,1.09 [0.78-1.52],0.602479278104723
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19220,129,0.86 [0.67-1.12],0.2613275651044657
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19180,89,0.80 [0.57-1.12],0.192508941847852
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19162,71,0.95 [0.69-1.30],0.7380428037006744
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19126,35,0.86 [0.53-1.42],0.5590151824887207
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19160,69,1.05 [0.79-1.39],0.7404533217334694
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Melanocytic naevi,23318,195,1.07 [0.91-1.26],0.3880755629267457
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23508,66,1.05 [0.78-1.39],0.7574367747109646
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Melanoma in situ,19119,72,1.05 [0.80-1.38],0.7356257362736087
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19161,70,0.89 [0.63-1.25],0.4995292449288367
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19219,128,0.99 [0.79-1.24],0.9225322017814516
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19293,202,1.07 [0.91-1.26],0.427943280611933
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19171,80,1.08 [0.83-1.39],0.5724616062144265
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Other benign neoplasms of skin,23351,151,0.77 [0.59-1.00],0.0526832457816938
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19884,793,1.06 [0.98-1.15],0.1350064369835943
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19918,827,1.05 [0.97-1.14],0.2127827813127324
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23273,336,1.04 [0.92-1.18],0.5404444082251536
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21837,84,1.11 [0.88-1.41],0.3740324426683648
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23007,70,1.13 [0.87-1.46],0.3573370031498567
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22681,2535,0.99 [0.94-1.04],0.6373679073441445
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22166,27,1.01 [0.63-1.62],0.9797026188331988
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23207,43,0.91 [0.60-1.39],0.6748194492580402
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23046,1293,0.96 [0.90-1.04],0.3170312757470804
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23046,1293,0.96 [0.90-1.04],0.3170312757470804
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21820,67,1.31 [1.06-1.62],0.0129462168527943
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23192,1053,1.03 [0.95-1.11],0.4823009451746241
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23264,100,1.00 [0.78-1.29],0.9701419235641052
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22982,45,0.68 [0.40-1.16],0.1567845632599501
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22988,51,0.99 [0.70-1.41],0.971890128294752
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23365,201,1.03 [0.87-1.22],0.7429211433140346
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23455,51,1.21 [0.93-1.59],0.1604895223220425
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23337,173,1.07 [0.90-1.28],0.4205672722422798
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22253,114,0.91 [0.71-1.18],0.4920025651929395
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,18991,202,0.93 [0.77-1.13],0.4927445864197103
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22322,57,0.88 [0.60-1.28],0.4955119144023315
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22318,53,0.84 [0.55-1.27],0.409300390134434
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18832,43,1.21 [0.90-1.64],0.2091565853308304
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21590,55,1.31 [1.03-1.67],0.0284755948684883
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21313,205,1.01 [0.85-1.20],0.9037480431817676
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23174,411,0.98 [0.86-1.11],0.7403639441961499
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23018,255,1.05 [0.91-1.22],0.4899680609501099
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22824,61,1.07 [0.80-1.44],0.647919475598707
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23217,1682,0.97 [0.91-1.03],0.3684687937693108
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20882,1643,0.97 [0.91-1.03],0.3012699220547765
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18833,44,0.83 [0.53-1.31],0.4280508815145323
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20937,99,0.99 [0.77-1.28],0.9316856093707544
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19025,236,1.08 [0.93-1.26],0.2861065265991173
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18830,41,0.86 [0.55-1.36],0.518650554707228
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21478,2689,0.96 [0.92-1.02],0.1665409521213239
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,18971,182,1.18 [1.02-1.38],0.030217035299586
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19252,463,1.07 [0.96-1.19],0.2306169743870173
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23464,303,1.02 [0.89-1.18],0.7594966034274176
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23302,141,1.12 [0.93-1.35],0.2337437295630301
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,18878,89,1.05 [0.81-1.35],0.7249513643432365
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18839,50,0.97 [0.68-1.40],0.8811869576203802
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22793,1955,1.04 [0.99-1.10],0.1480032081832809
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,18959,170,1.07 [0.89-1.28],0.4535436894623289
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,18957,168,0.96 [0.78-1.18],0.6740449124153485
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19246,457,0.90 [0.78-1.02],0.1050026846203497
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,18857,68,0.99 [0.73-1.35],0.9461102705743768
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23297,136,1.14 [0.94-1.37],0.1779722500151149
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19319,530,0.99 [0.88-1.10],0.7895873154485112
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19262,473,1.07 [0.96-1.19],0.2025222451150036
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21171,63,0.98 [0.71-1.36],0.91365102404586
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22799,4010,0.98 [0.94-1.02],0.4202924053491919
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20901,63,1.05 [0.78-1.42],0.7381572986376943
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20913,75,1.05 [0.80-1.38],0.7244816032490746
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23380,1758,1.02 [0.96-1.08],0.5335828538910754
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23384,1757,1.02 [0.96-1.08],0.5016956537310557
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20912,74,0.65 [0.42-1.00],0.0498330393427829
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23191,1353,1.08 [1.01-1.15],0.0197426534706774
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20061,1272,1.02 [0.95-1.09],0.5351555154625209
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23538,154,0.94 [0.75-1.17],0.5721261224652248
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22801,38,0.89 [0.56-1.42],0.6353424559437992
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21955,117,0.92 [0.71-1.18],0.5053318542878409
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22006,168,1.05 [0.87-1.26],0.6333643197301413
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19003,214,1.09 [0.93-1.27],0.305000544799392
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21981,120,0.94 [0.74-1.21],0.6391326792586659
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1465,37,0.82 [0.48-1.38],0.4494418099095617
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1557,147,1.03 [0.84-1.27],0.7628085277546792
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21886,25,1.05 [0.64-1.70],0.8561368325924283
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1450,23,0.88 [0.47-1.64],0.683589293354274
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23143,1282,0.93 [0.86-1.00],0.0573062820953779
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23050,287,1.01 [0.87-1.16],0.9276205852782656
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21515,407,1.08 [0.97-1.21],0.1746251575287961
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19394,605,1.04 [0.94-1.14],0.4525690416929097
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23463,205,1.05 [0.89-1.24],0.5842365947795204
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22673,42,0.84 [0.53-1.34],0.4655963230601601
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22242,744,0.97 [0.88-1.06],0.4981059194471593
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22709,78,0.91 [0.66-1.25],0.5532860023013201
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22661,30,0.95 [0.59-1.55],0.8484417077428508
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22769,138,1.18 [0.99-1.40],0.0633318968600049
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15291,1234,0.99 [0.92-1.06],0.7750834278216443
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,AV-block,20661,205,0.95 [0.79-1.14],0.582093256883582
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23506,265,0.94 [0.80-1.11],0.4758592344630468
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,14162,105,0.72 [0.52-1.01],0.0546538712821385
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20570,114,1.01 [0.80-1.27],0.9569968022696862
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20525,69,0.99 [0.73-1.34],0.9378078196573182
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23544,27,0.99 [0.61-1.59],0.9518184859017828
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Conduction disorders,21075,619,0.98 [0.88-1.08],0.6646846890359934
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22762,1275,0.88 [0.81-0.95],0.00178235212835
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21196,6248,0.97 [0.94-1.00],0.0883025916560289
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22270,218,1.07 [0.92-1.26],0.3730330684290345
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Endocarditis,20502,46,1.07 [0.76-1.50],0.6911985119588981
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23462,714,0.94 [0.85-1.04],0.2552634325346398
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Hypertension,21731,5263,0.97 [0.93-1.00],0.0548594888271454
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21740,5272,0.97 [0.93-1.00],0.0580233851242911
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23449,36,1.25 [0.90-1.72],0.1788060414605339
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16614,146,1.06 [0.87-1.29],0.5439978149823262
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16533,65,0.98 [0.71-1.35],0.904655288146542
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Hypotension,23431,909,0.99 [0.91-1.07],0.7606897557879863
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22898,80,1.04 [0.79-1.36],0.7809355537829118
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22942,1444,0.92 [0.86-0.99],0.0274849282960333
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23277,391,1.01 [0.89-1.14],0.8992504830712404
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20721,265,1.06 [0.92-1.23],0.4197908443130529
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23361,519,0.91 [0.81-1.03],0.1451390761302412
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21913,415,0.85 [0.74-0.98],0.0301829746792002
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23523,76,0.78 [0.54-1.13],0.1945081460209431
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23540,207,0.84 [0.68-1.03],0.0987624293822079
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22085,33,0.82 [0.48-1.40],0.4629732283144329
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other aneurysm,22680,49,0.90 [0.61-1.35],0.6154142557887966
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20770,314,0.95 [0.81-1.10],0.4671725952663494
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22691,60,0.91 [0.63-1.30],0.5923736870105878
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22799,168,1.10 [0.93-1.31],0.2790579435363763
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20601,145,0.92 [0.73-1.15],0.4558726065907008
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22125,73,1.10 [0.85-1.44],0.4682469663816883
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22093,41,1.32 [1.01-1.74],0.0451053424515657
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22481,30,1.15 [0.78-1.69],0.4824393111713736
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22186,134,1.13 [0.93-1.36],0.2184058599688413
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21119,663,1.00 [0.91-1.11],0.9257791323843816
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22558,36,0.64 [0.34-1.19],0.1580032090592691
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23066,435,1.03 [0.92-1.16],0.5892728771712401
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23047,277,1.11 [0.97-1.27],0.118777308699063
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22909,458,0.88 [0.77-1.00],0.0572222971274119
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14305,248,0.94 [0.79-1.12],0.4857206436248777
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22862,242,0.99 [0.84-1.16],0.8790951678524582
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22338,286,1.05 [0.91-1.21],0.4830293144383675
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23149,379,1.06 [0.94-1.19],0.3573497257750513
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23477,489,0.94 [0.83-1.06],0.3160744931906223
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20638,182,0.94 [0.77-1.15],0.5397667844669487
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23040,270,1.11 [0.96-1.27],0.1554783562828266
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22581,130,0.92 [0.72-1.17],0.5011784656187335
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23268,450,1.02 [0.91-1.15],0.6940717651751811
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23243,489,1.02 [0.91-1.14],0.7247601424056684
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22865,58,0.98 [0.70-1.37],0.9206418176633068
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22668,37,0.69 [0.38-1.23],0.2032438443688402
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23069,183,0.95 [0.78-1.16],0.6319144466652123
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23015,173,0.95 [0.78-1.16],0.6104498568401583
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Varicose veins,22432,380,1.05 [0.93-1.19],0.4334897568741432
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22640,80,1.01 [0.77-1.33],0.9398796457710816
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23365,602,1.04 [0.94-1.15],0.4217077859718232
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23511,188,0.97 [0.81-1.17],0.7530770904738562
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20923,1579,1.06 [1.00-1.12],0.061586606111568
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,Any mental disorder,23031,3687,1.00 [0.96-1.04],0.9080500506395028
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23486,223,1.00 [0.85-1.18],0.990296030195836
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21042,1698,0.98 [0.92-1.04],0.4324164765970877
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19423,79,0.85 [0.60-1.18],0.3311921604218846
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,Smoking dependency,23200,1024,0.97 [0.90-1.05],0.4825454873706407
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20531,1187,0.96 [0.89-1.03],0.2718218180793377
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,Vascular dementia,23129,90,1.01 [0.78-1.31],0.9148286500126273
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23546,317,1.05 [0.92-1.19],0.4958104748076369
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",16123,49,1.12 [0.83-1.51],0.4619982558349019
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Bell's palsy,21703,68,1.04 [0.78-1.39],0.7888506853616883
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22191,556,0.92 [0.82-1.04],0.1692331082756955
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Cerebral cysts,23202,180,1.07 [0.90-1.26],0.4699860564139922
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23482,233,1.00 [0.85-1.18],0.998487859067124
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23132,39,1.06 [0.73-1.54],0.772488065384408
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23535,43,1.18 [0.86-1.61],0.2998303600554303
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23064,42,0.81 [0.50-1.30],0.3829661216722658
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Epilepsy,22289,242,0.93 [0.78-1.10],0.384389676352981
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23182,1135,0.90 [0.83-0.98],0.0167200762326679
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23503,307,1.07 [0.94-1.22],0.3344269449380656
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23014,2472,0.99 [0.94-1.05],0.8153314205751341
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23236,41,0.94 [0.62-1.43],0.7843882383592522
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Hemiplegia,23434,185,1.01 [0.84-1.22],0.8810166184404731
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Hydrocephalus,23077,55,0.75 [0.48-1.18],0.2115575748729217
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23528,66,0.75 [0.50-1.13],0.1688350296074497
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21745,110,1.06 [0.85-1.32],0.6278792087099325
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21688,53,0.90 [0.61-1.32],0.595777240339001
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Memory loss,23021,91,0.86 [0.64-1.17],0.3452239472596619
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Migraine,22486,439,0.90 [0.79-1.03],0.1286541682214825
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23445,398,0.94 [0.82-1.07],0.369808059935745
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Motor neuron disease,16214,116,0.96 [0.76-1.23],0.7662897136147839
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23348,124,0.67 [0.49-0.92],0.0146689303949137
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22835,1200,0.96 [0.89-1.03],0.2700158239582965
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Neurological diseases,22154,3176,0.99 [0.94-1.03],0.5149999944196963
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23216,123,0.94 [0.74-1.20],0.6420344830578296
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22000,365,1.02 [0.90-1.16],0.7054875066823278
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23495,191,1.13 [0.96-1.32],0.1405374861964991
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19039,569,0.99 [0.89-1.10],0.8217933192619364
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23079,57,1.15 [0.87-1.52],0.3291316018698328
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23131,109,0.77 [0.56-1.05],0.0973192642669481
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23336,140,1.12 [0.93-1.34],0.2426961166705727
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21711,76,0.96 [0.71-1.30],0.8081514868337047
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other headache syndromes,22111,64,0.54 [0.32-0.90],0.0187299053174652
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23446,424,0.98 [0.86-1.11],0.7008387177496052
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22389,342,0.85 [0.73-1.00],0.0552812681010909
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23523,146,1.05 [0.87-1.28],0.5974642922816655
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23091,69,1.06 [0.80-1.39],0.6905184064174192
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23545,75,1.16 [0.92-1.48],0.2134565718370379
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23393,275,0.91 [0.77-1.08],0.2932363263324752
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23338,34,1.22 [0.87-1.71],0.2579948087480866
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23536,141,0.95 [0.76-1.19],0.6687598940515682
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21693,58,0.44 [0.24-0.80],0.0076330401319576
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23546,320,1.04 [0.91-1.19],0.5680558771501023
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23089,87,0.96 [0.73-1.26],0.7599458322448178
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23042,91,0.71 [0.50-1.02],0.0649261404106665
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23155,411,1.04 [0.92-1.17],0.5344156960994907
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23422,138,0.92 [0.73-1.17],0.5094571699766834
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22585,52,0.98 [0.68-1.39],0.8995805818581617
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22580,47,1.16 [0.86-1.57],0.317622659681927
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23440,55,1.26 [0.98-1.63],0.0690863177980512
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23304,143,1.12 [0.93-1.34],0.2349826905060213
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1456,28,0.84 [0.46-1.52],0.5648640201150046
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1741,54,0.82 [0.53-1.25],0.3543357587028113
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23033,82,1.06 [0.82-1.37],0.6359774420629793
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23399,893,0.97 [0.89-1.06],0.4897975683253762
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23178,645,1.08 [0.98-1.18],0.109180044151953
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22794,261,1.08 [0.93-1.24],0.3085300161788337
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23472,728,1.05 [0.96-1.14],0.3143238331460092
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23535,63,1.15 [0.88-1.50],0.3030757770574286
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23406,662,1.07 [0.98-1.17],0.1541599113672133
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23510,349,1.01 [0.89-1.15],0.8606580994928297
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23463,178,0.86 [0.69-1.07],0.1752484677341756
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22569,36,0.83 [0.50-1.38],0.4685941688804349
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22573,40,0.55 [0.29-1.05],0.0707098703793226
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22595,62,1.04 [0.77-1.41],0.8041107276590218
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23468,613,1.07 [0.98-1.18],0.1441715021772661
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23004,149,0.84 [0.66-1.08],0.174354457917368
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22800,56,1.00 [0.71-1.40],0.9964119277517848
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23247,86,0.72 [0.49-1.04],0.0780385031375263
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23434,273,1.10 [0.96-1.26],0.1718278543870718
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22924,180,1.14 [0.97-1.33],0.1206856003592483
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23401,116,0.89 [0.69-1.16],0.3987611669494667
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23254,399,1.05 [0.93-1.19],0.3960920355280775
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23083,132,0.95 [0.76-1.20],0.6736236923194254
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22004,2181,1.01 [0.96-1.07],0.671326138092325
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23400,239,1.13 [0.98-1.30],0.0872286771303324
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23526,139,0.95 [0.76-1.19],0.633745415230734
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22865,332,1.08 [0.95-1.22],0.2449209168815193
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23219,58,0.83 [0.55-1.23],0.3440583655778366
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23521,49,1.24 [0.94-1.63],0.1306238770283355
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22613,80,1.06 [0.82-1.38],0.6642277117181221
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22661,128,1.14 [0.95-1.38],0.1582643091845567
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22595,89,0.77 [0.55-1.09],0.1378555017585364
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22800,56,0.84 [0.56-1.25],0.3810029092135607
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22561,55,0.87 [0.59-1.28],0.474295142323181
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22958,103,1.14 [0.92-1.41],0.222877030249141
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23010,155,1.10 [0.91-1.31],0.3251445357231914
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22643,110,1.18 [0.97-1.44],0.0911843368805075
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22585,79,1.18 [0.95-1.48],0.1396908131371891
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22563,57,0.73 [0.46-1.14],0.1681369381907088
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21612,1789,0.99 [0.93-1.05],0.7702635250818607
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22608,75,1.09 [0.84-1.42],0.5003556047319073
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23321,370,0.90 [0.78-1.04],0.166707444535256
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22992,41,0.82 [0.50-1.33],0.4116726459020228
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23097,146,1.05 [0.86-1.28],0.6171601074971009
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23325,98,0.90 [0.68-1.20],0.4756727535976941
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23505,94,1.09 [0.87-1.38],0.4489434302529911
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23441,124,0.74 [0.55-0.99],0.0460324647143665
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23291,64,1.17 [0.90-1.51],0.2301988322245396
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23294,67,1.00 [0.74-1.35],0.9965170773486002
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23455,690,0.94 [0.85-1.04],0.2323763417051811
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23234,469,0.96 [0.86-1.09],0.5523825623537875
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22866,101,1.01 [0.79-1.30],0.9145084464574584
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22839,74,0.97 [0.72-1.30],0.8291981844371079
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23302,73,0.86 [0.61-1.20],0.3704525473509882
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23438,209,1.05 [0.90-1.24],0.5366344022631823
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23287,58,1.17 [0.90-1.53],0.230889060488544
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,All influenza,22103,112,1.10 [0.88-1.36],0.4019425942583179
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22102,111,1.09 [0.87-1.35],0.4561038620301091
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16763,113,1.26 [1.06-1.50],0.0105104694925022
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23425,246,1.08 [0.93-1.24],0.3244477661658259
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18285,1795,1.02 [0.96-1.08],0.4670887364585614
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18421,1771,1.01 [0.95-1.07],0.6911083074609938
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23190,115,1.17 [0.96-1.42],0.1186042577675147
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22051,60,1.37 [1.10-1.71],0.0045815936124622
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Bronchiectasis,20340,341,0.74 [0.62-0.89],0.0014082990189476
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20059,60,0.87 [0.59-1.26],0.4570137954517755
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22554,2555,1.01 [0.96-1.06],0.6358012274606429
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22442,57,0.98 [0.70-1.38],0.9199433711089726
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22511,126,0.91 [0.72-1.17],0.470490124149452
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23398,889,1.01 [0.93-1.10],0.8340159325170944
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22450,65,0.90 [0.64-1.27],0.560638212142444
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21752,4396,1.00 [0.96-1.04],0.9813247463298198
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22678,293,0.93 [0.79-1.09],0.3456246045928807
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Early onset COPD,22782,273,1.01 [0.88-1.16],0.9286647162092436
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Emphysema,20226,227,1.12 [0.97-1.31],0.1271298092983717
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22088,200,0.92 [0.76-1.11],0.3868529871408852
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23374,1383,1.04 [0.98-1.11],0.2195238020740987
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22123,235,0.91 [0.76-1.09],0.2899495757525971
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Later onset COPD,22756,616,1.00 [0.90-1.11],0.9772694563561628
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23540,185,0.96 [0.79-1.16],0.6767940637098351
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Nasal polyp,22443,58,0.97 [0.70-1.36],0.8665329586021716
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23347,792,1.00 [0.91-1.09],0.9924585602750456
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23384,1489,1.01 [0.95-1.08],0.8014628776008494
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23067,682,0.99 [0.90-1.09],0.8990773679332462
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other pleural conditions,21929,34,0.64 [0.34-1.22],0.1757176439685633
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23471,297,0.91 [0.78-1.07],0.2739065944161045
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23467,1014,1.04 [0.97-1.13],0.2661314015305462
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pleural effusion,22597,702,0.98 [0.88-1.08],0.6175433619376984
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pleural plaque,21938,43,0.96 [0.64-1.43],0.8406273228478313
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23166,1175,1.04 [0.97-1.11],0.3116916592129102
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23514,159,0.93 [0.75-1.15],0.5095756465452699
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pneumothorax,21982,87,1.00 [0.77-1.32],0.9724777976063868
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pollen allergy,23521,207,1.09 [0.94-1.28],0.2522435119411921
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23227,53,0.88 [0.59-1.31],0.5168708466822383
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16693,43,0.97 [0.66-1.42],0.8767417597270383
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23328,773,0.99 [0.91-1.09],0.8807139301632322
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22631,246,1.08 [0.93-1.24],0.3250003846782789
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Viral pneumonia,22173,182,1.01 [0.83-1.21],0.9559296579514092
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23196,142,0.91 [0.72-1.15],0.4451094933729128
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11349,90,0.96 [0.72-1.26],0.7561213563010154
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16830,34,0.76 [0.44-1.32],0.3268578769101308
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23378,115,0.95 [0.75-1.21],0.7007363332184701
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute gastritis,17701,74,1.01 [0.75-1.34],0.970296625731896
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21586,140,1.04 [0.85-1.28],0.6720250717017022
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute peritonitis,23062,72,1.12 [0.87-1.45],0.3713434803514573
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22817,31,1.25 [0.88-1.76],0.209811681890585
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,17918,291,0.98 [0.85-1.14],0.842518218857748
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21513,67,1.19 [0.92-1.53],0.1817487443846581
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23188,67,1.18 [0.92-1.52],0.200574261038958
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Cholecystitis,21598,152,1.13 [0.94-1.35],0.195487880257469
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22480,1034,1.06 [0.99-1.14],0.1036304264964595
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Chronic gastritis,17917,290,1.06 [0.92-1.21],0.4456123606273017
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21482,36,0.91 [0.57-1.44],0.685487627849173
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23477,64,1.23 [0.97-1.58],0.0934462359850072
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Coeliac disease,22232,124,1.17 [0.97-1.40],0.1005999033025727
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Collagenous colitis,21924,89,1.09 [0.86-1.39],0.4657747711726322
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23425,140,0.95 [0.76-1.18],0.6182263458292037
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Constipation,23252,1456,0.94 [0.88-1.01],0.0942548764350523
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Crohn disease,21906,71,1.03 [0.78-1.37],0.8318158206753553
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23238,49,0.96 [0.66-1.39],0.8313649768179383
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21909,74,1.02 [0.77-1.35],0.9002831946668131
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Dental caries,22834,197,1.02 [0.86-1.21],0.8224479237760283
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22148,2091,0.98 [0.93-1.04],0.4615963618435698
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23415,152,1.00 [0.82-1.22],0.9688958012415628
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of liver,23462,676,0.97 [0.87-1.07],0.4894235820110078
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21569,3942,1.02 [0.98-1.06],0.4488731242917565
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23141,504,1.06 [0.95-1.17],0.2959123755094506
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23437,447,1.08 [0.97-1.20],0.1550387435174189
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22735,98,0.94 [0.72-1.23],0.6507184724216282
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22608,55,0.87 [0.59-1.29],0.4946300476113124
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23292,1184,1.02 [0.95-1.10],0.5698796557360314
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22614,88,1.17 [0.94-1.45],0.1589642860244208
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22816,1370,1.05 [0.98-1.12],0.1619408607468407
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19548,2752,1.00 [0.95-1.05],0.9553810278223144
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17742,115,0.83 [0.63-1.11],0.2073509111651259
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23497,95,0.80 [0.58-1.10],0.1658394849615865
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23463,55,1.10 [0.83-1.46],0.5145628929125536
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22867,81,1.13 [0.89-1.44],0.3188538617664864
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16898,102,0.95 [0.74-1.23],0.6914804530341149
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18200,573,0.97 [0.87-1.08],0.5632984729977337
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastric ulcer,17926,299,1.09 [0.95-1.24],0.2157887630462816
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20002,2375,1.00 [0.95-1.05],0.9329476997671768
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18040,413,1.04 [0.92-1.17],0.5205630930105123
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18412,7211,1.02 [0.99-1.05],0.1163961974925903
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,GI-bleeding,23053,945,1.01 [0.93-1.09],0.8652270942540257
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22697,60,1.24 [0.97-1.58],0.0908596565149838
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17639,1094,1.01 [0.93-1.08],0.8763673185256593
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22817,31,1.09 [0.72-1.66],0.6859952138274701
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Hernia,22529,2472,0.98 [0.93-1.03],0.3444461834968392
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Impacted teeth,23471,50,1.07 [0.79-1.46],0.6564743123609648
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Impaction of intestines,16856,60,0.92 [0.65-1.31],0.6412633130326808
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Inguinal hernia,20202,145,1.14 [0.96-1.36],0.1436738559442401
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16877,81,1.17 [0.93-1.47],0.1747573229157983
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22258,150,1.09 [0.91-1.31],0.3524518142074865
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17486,690,0.97 [0.88-1.07],0.6025574500498954
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23537,296,0.86 [0.72-1.02],0.0822486929229969
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22528,693,1.03 [0.94-1.13],0.4655005232244027
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22767,932,1.02 [0.94-1.10],0.7048458361951965
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17756,129,1.04 [0.84-1.28],0.7407675499697899
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Oesophagitis,18113,486,1.01 [0.91-1.13],0.8112908756726597
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23505,136,0.87 [0.68-1.12],0.2834667932851867
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20109,52,1.13 [0.84-1.53],0.4156123655249444
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17876,1080,0.98 [0.91-1.06],0.6936529502687889
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21698,252,0.99 [0.84-1.16],0.892930984187398
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21608,162,1.11 [0.93-1.32],0.263039659303081
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18150,1354,0.98 [0.92-1.05],0.6516838218327705
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21672,4876,0.98 [0.95-1.02],0.3950477350700648
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22612,197,0.93 [0.77-1.13],0.4804602335432064
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23350,564,0.95 [0.85-1.06],0.341299134231483
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18126,499,1.03 [0.92-1.15],0.6239747521148862
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21576,130,0.85 [0.66-1.11],0.2280007382618219
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23382,392,1.13 [1.02-1.26],0.0243691938698001
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18546,919,0.98 [0.90-1.07],0.6897098826326494
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23068,960,1.00 [0.93-1.09],0.9413850755809656
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22786,149,0.95 [0.76-1.18],0.619996502816216
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18302,1506,0.94 [0.87-1.00],0.0581462502180437
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19423,1796,0.98 [0.93-1.04],0.5798014434979449
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22873,87,1.04 [0.81-1.35],0.7498791900310973
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22656,821,1.02 [0.94-1.11],0.6469975211623131
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17082,286,0.91 [0.77-1.07],0.2410865013439107
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23453,64,1.07 [0.81-1.40],0.638707462439247
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17221,425,0.95 [0.84-1.08],0.4378995023065213
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22227,119,0.97 [0.77-1.23],0.800784572016555
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23538,63,1.30 [1.04-1.63],0.0188447216411542
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22636,113,1.31 [1.11-1.54],0.0013340490533092
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Toxic colitis,21890,55,1.02 [0.73-1.42],0.8948561229598105
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17835,208,1.02 [0.86-1.21],0.8472455713181972
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21982,147,0.95 [0.77-1.18],0.6673613295662784
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21959,124,0.93 [0.73-1.18],0.5566063629248741
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20205,148,0.84 [0.66-1.08],0.1741742296034936
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16960,164,1.01 [0.83-1.23],0.911080012032273
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Ventral hernia,20272,215,0.95 [0.79-1.14],0.5921421473176329
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Volvulus,16868,72,0.94 [0.69-1.29],0.7040962633002823
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23471,216,1.12 [0.96-1.29],0.1469523389710536
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23269,77,1.01 [0.76-1.33],0.9515143581497476
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21794,196,0.92 [0.75-1.11],0.381825818382528
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23078,543,1.08 [0.98-1.19],0.1162317137284582
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22662,127,1.08 [0.88-1.33],0.443929047001025
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21875,277,1.01 [0.87-1.17],0.8847860048101335
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23271,240,1.01 [0.86-1.18],0.8963621957853989
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23449,418,1.01 [0.90-1.14],0.8384819576232392
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23075,44,1.08 [0.77-1.52],0.6525484579054264
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22182,2733,0.99 [0.95-1.04],0.7769653368600411
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23165,402,0.97 [0.85-1.10],0.5951962275098718
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23036,273,0.93 [0.80-1.10],0.410499290031118
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23265,730,1.06 [0.97-1.15],0.219012943336215
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23528,66,0.99 [0.72-1.34],0.925389946211158
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21686,88,0.93 [0.70-1.24],0.6282241131354601
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22804,41,1.00 [0.67-1.48],0.9904988234529936
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23257,226,0.99 [0.84-1.17],0.8827243239502442
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21957,359,1.02 [0.90-1.16],0.7531148202458822
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21643,45,0.98 [0.67-1.44],0.9209693491749208
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23457,68,0.97 [0.71-1.32],0.8306248099109891
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22664,129,0.97 [0.77-1.22],0.8103011751494502
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23342,150,0.95 [0.77-1.18],0.648509536160105
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23074,43,0.98 [0.66-1.46],0.9251027918272658
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21654,56,0.77 [0.50-1.19],0.2398856939221084
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22969,1371,0.98 [0.92-1.05],0.586426831925802
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21988,390,1.01 [0.90-1.15],0.8271484116322626
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21647,49,0.96 [0.66-1.40],0.8424938471354431
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23474,282,0.94 [0.81-1.10],0.4691972960284363
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23105,74,1.07 [0.81-1.40],0.6425270642813216
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23411,219,0.92 [0.77-1.11],0.3847701755389222
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23498,243,1.08 [0.94-1.25],0.287806962835112
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21741,143,0.85 [0.66-1.08],0.1889420190492471
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21821,223,1.00 [0.85-1.18],0.9850263372614252
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23486,231,1.09 [0.94-1.27],0.2343241935026979
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21768,170,1.11 [0.93-1.31],0.2485653358258861
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23514,125,1.01 [0.81-1.26],0.956967475208138
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20085,116,1.06 [0.85-1.31],0.6030870999643516
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21374,5488,1.01 [0.98-1.04],0.5537740921746837
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20191,4305,1.01 [0.97-1.05],0.6769774051857393
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20033,64,1.18 [0.92-1.52],0.1941129781925021
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20203,134,1.00 [0.81-1.25],0.9672686925585484
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20247,178,1.02 [0.85-1.22],0.8421393003545314
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23298,101,0.90 [0.68-1.19],0.4456643142591215
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20169,100,1.00 [0.78-1.29],0.9979835620977108
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17077,1191,0.99 [0.92-1.07],0.8064556553547374
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23410,200,0.80 [0.64-1.00],0.0470936096309987
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20567,498,1.00 [0.89-1.12],0.9942647765996294
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19768,6995,1.01 [0.98-1.04],0.3711497823676642
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21086,122,0.76 [0.56-1.02],0.0678983498185207
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20087,118,1.09 [0.88-1.34],0.4253440905973491
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20562,593,1.08 [0.98-1.18],0.1244520271762755
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22665,2596,0.99 [0.94-1.04],0.7447058798379982
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20121,152,0.89 [0.71-1.12],0.3137209561468683
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20300,331,0.97 [0.84-1.12],0.6562782453315343
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20120,151,1.06 [0.88-1.28],0.5677690837914204
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22690,94,0.66 [0.46-0.97],0.0326286289910951
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17516,1630,1.02 [0.96-1.08],0.5832112344248325
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16064,178,0.96 [0.79-1.18],0.7103225268426443
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23533,175,0.95 [0.77-1.16],0.602192754092617
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15975,89,1.06 [0.83-1.35],0.6475946421582279
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16383,497,1.08 [0.97-1.19],0.1672787706198553
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20257,288,1.14 [1.00-1.29],0.0434238813860643
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16442,556,0.94 [0.84-1.06],0.3031768605834734
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20126,57,1.06 [0.78-1.45],0.7074719141278696
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20689,620,0.97 [0.87-1.07],0.5198835925308589
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20358,289,0.97 [0.83-1.13],0.7012862263995376
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16402,516,0.94 [0.84-1.06],0.3295857290051196
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20042,73,0.88 [0.63-1.23],0.4571859615875893
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20027,58,1.03 [0.75-1.41],0.8556746883900859
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21007,43,0.67 [0.39-1.16],0.1528491168398718
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23136,2172,0.96 [0.91-1.01],0.1364607844280219
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22527,1563,0.96 [0.90-1.03],0.2606453944958746
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23368,517,0.94 [0.84-1.06],0.3156007489415257
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18518,2632,1.03 [0.98-1.08],0.1929075989319911
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,15946,60,1.11 [0.84-1.47],0.4649724039645108
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20057,88,1.02 [0.78-1.32],0.8980479615047816
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,15927,41,1.09 [0.76-1.56],0.6562431776494053
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16065,179,1.15 [0.98-1.35],0.0806161345090371
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21223,259,0.99 [0.85-1.16],0.9298527358424228
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21450,486,0.97 [0.86-1.09],0.6084286487269422
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23522,92,0.96 [0.73-1.26],0.7788322439790467
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21828,1759,0.99 [0.93-1.05],0.6887771922662448
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20081,112,0.98 [0.77-1.24],0.8537210846081971
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16092,206,1.05 [0.89-1.24],0.557145138743731
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20767,698,1.01 [0.92-1.11],0.8706870917257837
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18080,2194,0.99 [0.94-1.05],0.7686529121923213
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22708,112,0.71 [0.51-0.99],0.0413612106014199
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23529,75,1.04 [0.79-1.37],0.7652304868252137
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20035,66,1.12 [0.86-1.47],0.3996661678994737
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21239,1270,1.01 [0.94-1.08],0.8239502791715081
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20041,72,1.14 [0.88-1.46],0.3177163044659519
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17595,1709,1.02 [0.96-1.08],0.5658840804404447
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21091,127,1.05 [0.86-1.30],0.6182211966807485
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20016,47,0.96 [0.66-1.40],0.8343767269560595
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20243,174,1.02 [0.85-1.23],0.7944520126322545
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20474,505,1.03 [0.93-1.15],0.540567256543443
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23042,446,0.94 [0.83-1.06],0.319103222420241
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20624,555,0.98 [0.88-1.10],0.7530098171337056
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23378,499,0.93 [0.83-1.05],0.2686141223903305
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23520,58,0.91 [0.63-1.31],0.5985292214633366
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20160,191,1.10 [0.93-1.29],0.2739008635173809
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18052,780,1.00 [0.91-1.09],0.999922775470958
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20537,568,1.03 [0.93-1.14],0.5861330870093613
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20071,102,0.92 [0.70-1.21],0.5491588621658885
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",15958,72,1.16 [0.91-1.49],0.2338769722737963
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18165,2279,1.00 [0.95-1.05],0.99300870504479
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16611,725,1.03 [0.94-1.13],0.5301209613666131
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22849,253,0.88 [0.74-1.05],0.1662920594056526
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23498,68,1.02 [0.76-1.37],0.8764429186948804
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21555,47,0.98 [0.67-1.43],0.9097570590174336
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,15962,76,1.04 [0.79-1.37],0.7636576093408276
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20167,98,1.15 [0.93-1.43],0.1977654596438896
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16407,521,0.97 [0.86-1.09],0.5941276682602723
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20246,277,1.06 [0.92-1.22],0.45769603519333
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20313,244,0.97 [0.82-1.14],0.6977050690149045
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20308,239,0.97 [0.82-1.15],0.7440874081023597
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18144,77,0.93 [0.69-1.27],0.6625431941484546
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23526,64,0.95 [0.68-1.32],0.7487843281602544
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20517,548,1.11 [1.01-1.22],0.0270128330837546
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22745,149,0.97 [0.78-1.19],0.7534728353513489
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22399,2430,1.03 [0.98-1.08],0.3143180257151228
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20103,134,0.96 [0.76-1.20],0.705550868014662
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20543,474,1.11 [1.01-1.23],0.0367224626339581
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22027,225,1.05 [0.90-1.23],0.507118383681363
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20279,210,1.09 [0.93-1.28],0.2834475271590442
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21552,1483,1.02 [0.96-1.09],0.4875968662937348
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21076,1007,1.00 [0.93-1.09],0.9357249831120362
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20024,55,1.21 [0.92-1.59],0.1754707010882125
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22808,212,1.19 [1.04-1.36],0.0141863639072302
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20142,173,1.01 [0.83-1.21],0.9550228213462616
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20082,113,1.10 [0.89-1.36],0.3919051791157746
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),15930,44,0.70 [0.41-1.20],0.1915962166499236
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22719,1027,1.05 [0.97-1.13],0.2364550823832957
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17606,86,0.97 [0.74-1.27],0.8422551828713762
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22949,98,1.01 [0.79-1.29],0.91613619006934
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23410,196,0.97 [0.81-1.17],0.7726985477018692
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23236,22,0.62 [0.28-1.40],0.2504091109431093
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22834,1142,0.97 [0.90-1.05],0.4843306063701809
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23407,58,0.83 [0.56-1.24],0.360860033961033
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23376,199,1.06 [0.89-1.25],0.5119944347650507
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Cystitis,20807,215,1.06 [0.91-1.25],0.4430030984684168
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Dialysis,21735,43,1.10 [0.77-1.55],0.6084908337829125
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23131,280,1.04 [0.91-1.20],0.5490622089942327
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17668,148,1.00 [0.82-1.22],0.9898096836938554
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17861,341,0.99 [0.87-1.12],0.8538314200949751
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18383,863,1.03 [0.94-1.11],0.5439420544229734
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18308,4247,1.02 [0.98-1.06],0.3336877478730274
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23399,50,1.01 [0.71-1.44],0.96131351273181
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21571,181,0.96 [0.79-1.17],0.7063140729222708
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23077,343,1.01 [0.89-1.15],0.8736642648272058
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23150,110,0.77 [0.57-1.03],0.0773138457269149
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17787,267,1.03 [0.89-1.18],0.707821778103599
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20656,64,0.67 [0.43-1.05],0.0801311116686643
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19624,2104,1.02 [0.97-1.08],0.4128326714056078
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17638,118,1.05 [0.85-1.29],0.6809754562838304
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23537,57,0.98 [0.70-1.37],0.8937401034165956
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23537,67,1.06 [0.79-1.41],0.713052137480502
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22478,1886,1.03 [0.98-1.09],0.2292864131254082
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20997,405,1.04 [0.92-1.17],0.5664634465165386
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22951,100,1.05 [0.83-1.32],0.6930971784220498
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23496,319,1.09 [0.96-1.23],0.2052979026729073
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23494,74,1.25 [1.01-1.56],0.0403912149007771
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22204,1612,1.03 [0.97-1.09],0.3482804254663413
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22912,178,0.96 [0.79-1.17],0.692627622354607
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17656,136,0.81 [0.62-1.06],0.1214698800415376
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17858,338,0.98 [0.85-1.12],0.7671404345557805
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17621,101,0.87 [0.65-1.16],0.3387519335448867
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17696,176,1.12 [0.96-1.32],0.1584656202147367
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21615,225,0.96 [0.81-1.15],0.6731771063815246
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23282,105,1.22 [1.01-1.48],0.0371100474915589
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17783,263,1.11 [0.97-1.27],0.1246981360589589
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17610,90,1.09 [0.86-1.37],0.4829278734072342
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18073,553,0.98 [0.88-1.09],0.6774161906680956
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17656,136,0.90 [0.71-1.14],0.3916256001558331
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18026,506,1.02 [0.92-1.14],0.6817023964824891
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23382,33,1.04 [0.69-1.58],0.835954996643415
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23395,2005,0.99 [0.94-1.05],0.7354019082830257
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21538,148,0.82 [0.63-1.05],0.1114455992725536
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21772,80,1.15 [0.90-1.46],0.2628266432482668
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23242,28,1.02 [0.65-1.62],0.916211594396258
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20719,127,0.96 [0.76-1.21],0.7161185168148982
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23437,223,0.99 [0.84-1.17],0.8940804059670793
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17638,118,1.02 [0.82-1.27],0.8720306098525451
